ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
TRT Halves Risk of Death in Opiod Users
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Jinzang" data-source="post: 166465" data-attributes="member: 12925"><p>A new study reaffirms the benefits of TRT, at least among opioid users. The <a href="https://www.healio.com/endocrinology/hormone-therapy/news/online/%7B6d9e29f5-e6f8-4aa8-8ccc-44d77bcd597d%7D/testosterone-therapy-nearly-halves-mortality-cv-event-risks-for-opioid-users" target="_blank">article</a> says:</p><p></p><p>There may be mortality, musculoskeletal and cardiovascular benefits from testosterone therapy among men with low testosterone due to opioid use, according to findings published in <em>JAMA Network Open</em>.</p><p>Jasuja and colleagues assessed the risks for all-cause death, major adverse CV events, anemia and fractures at the femur, hip and vertebrae across 6 years in a cohort of 21,272 men using data from the Veteran’s Health Administration. Total testosterone levels less than 300 ng/dL or free testosterone levels less than 70 pg/mL were used as the criteria for low testosterone, which was present in all participants. The researchers also identified prescriptions for testosterone therapy of at least 120 days for 14,121 men (mean age, 52.8 years) and identified no prescriptions for testosterone therapy for 7,151 men(mean age 54.8 years).</p><p>There was a 49% reduction in all-cause mortality risk among testosterone users vs. nonusers (HR = 0.51; 95% CI, 0.42-0.61). Testosterone users also had a 42% reduction in major adverse CV event risk (HR = 0.58; 95% CI, 0.51-0.67) and a 32% reduction in fracture risk at the femur or hip (HR = 0.68; 95% CI, 0.48-0.96). The researchers also observed an association between testosterone therapy and anemia resolution, with the likelihood of resolution 16% greater for testosterone therapy users vs. nonusers (HR = 1.16; 95% CI, 1.02-1.31). Sensitivity analyses that included considerations for cancer, glucocorticoid medications and propensity score matching did not significa</p></blockquote><p></p>
[QUOTE="Jinzang, post: 166465, member: 12925"] A new study reaffirms the benefits of TRT, at least among opioid users. The [URL='https://www.healio.com/endocrinology/hormone-therapy/news/online/%7B6d9e29f5-e6f8-4aa8-8ccc-44d77bcd597d%7D/testosterone-therapy-nearly-halves-mortality-cv-event-risks-for-opioid-users']article[/URL] says: There may be mortality, musculoskeletal and cardiovascular benefits from testosterone therapy among men with low testosterone due to opioid use, according to findings published in [I]JAMA Network Open[/I]. Jasuja and colleagues assessed the risks for all-cause death, major adverse CV events, anemia and fractures at the femur, hip and vertebrae across 6 years in a cohort of 21,272 men using data from the Veteran’s Health Administration. Total testosterone levels less than 300 ng/dL or free testosterone levels less than 70 pg/mL were used as the criteria for low testosterone, which was present in all participants. The researchers also identified prescriptions for testosterone therapy of at least 120 days for 14,121 men (mean age, 52.8 years) and identified no prescriptions for testosterone therapy for 7,151 men(mean age 54.8 years). There was a 49% reduction in all-cause mortality risk among testosterone users vs. nonusers (HR = 0.51; 95% CI, 0.42-0.61). Testosterone users also had a 42% reduction in major adverse CV event risk (HR = 0.58; 95% CI, 0.51-0.67) and a 32% reduction in fracture risk at the femur or hip (HR = 0.68; 95% CI, 0.48-0.96). The researchers also observed an association between testosterone therapy and anemia resolution, with the likelihood of resolution 16% greater for testosterone therapy users vs. nonusers (HR = 1.16; 95% CI, 1.02-1.31). Sensitivity analyses that included considerations for cancer, glucocorticoid medications and propensity score matching did not significa [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
TRT Halves Risk of Death in Opiod Users
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top